Adamas Pharmaceuticals Was Bought Out and Flexion Therapeutics in Talks for a Buyout Offer 💰

Adamas Pharmaceuticals Was Bought Out and Flexion Therapeutics in Talks for a Buyout Offer

Adamas Pharmaceuticals

Adamas Pharmaceuticals is a healthcare company located in Oakland, California. They focus on drug manufacturing, and they discover and develop drugs for neurologic diseases in the United States.

On Monday, it was announced that Adamas was bought out by Supernus Pharmaceuticals, another biotech firm, for about $400 million. This gives Supernus access to possible Parkinson’s drugs, along with other neurological disorders. Shareholders of Adamas are receiving $8.10 per share, and they get additional benefits depending on how the drugs perform. Due to the news, Adamas closed the day at $8.07, up 75.05%.

Flexion Therapeutics

Flexion Therapeutics is a healthcare company that is on the other side of the US in Boston, Massachusetts. They focus on creating drugs to solve muscular system disorders, and they have a market cap of $461.179 million.

Flexion announced on Monday that they were nearing a deal for Pacira BioSciences to buy them for $630 million. It is a massive premium to Flexion’s market cap last week, and it diversifies Pacira’s non-opioid drugs. It also allows for Flexion’s drugs to be more available for consumers, which can help treat many. Overall, investors loved the acquisition as Flexion ended the day at $9.17, up 58.65%.

I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.

Share:

More Posts

Get your daily Invstr Crunch

Get the market news and updates you need, delivered to your inbox or available on our daily podcast.

Risk Disclosure:

Invstr is not a bank and banking services are provided by Vast Bank, N.A.

Brokerage and Banking services are currently only available to U.S. residents.

Invstr app and web services are provided by Invstr Ltd. Advisory services are provided by Invstr Financial LLC, an investment adviser registered with the Securities Exchange Commission (SEC) details of which can be obtained here. Securities brokerage and custody services are provided by Apex Clearing, a broker dealer registered with the SEC and a member of FINRA and SIPC. There is no bank guarantee on securities and securities may lose value.

Investing involves risk and can lead to losses. Past performance does not guarantee future results.

Invstr app and web services are provided by Invstr Ltd. Invstr+ advisory services are provided by Invstr Financial LLC, an investment adviser registered with the Securities Exchange Commission (SEC). Securities brokerage and custody services are provided by Apex Clearing, a broker dealer registered with the SEC and a member of FINRA and SIPC. There is no bank guarantee on securities and securities may lose value. Vast Bank N.A. a nationally chartered bank and member of the FDIC, provides the banking products, including the products and services related to digital asset accounts. As with any asset, the value of Digital assets can go up or down and there can be a substantial risk that you lose money buying or holding digital assets. You should carefully consider whether trading or holding Digital assets is suitable for you in light of your financial condition. Your digital account does not support wallet to wallet transferring of your digital assets (i.e. cryptocurrencies) outside the platform. Any Digital Assets in your digital asset account are not insured by any government entities, including but not limited to FDIC or SIPC. The Invstr Visa® Debit Card is issued by Vast Bank, N.A. pursuant to a license from Visa U.S.A Inc and may be used everywhere Visa debit cards are accepted. Invstr Ltd, Invstr Financial LLC and Invstr Securities Ltd are subsidiaries of Marketspringpad Holdings (collectively “Invstr”) and Invstr is solely responsible for the application services and website content.

Watchlists provided when users first access the service are not a recommendation to invest. Instead they are provided to help users better navigate the service. Users are free to edit and create their own watchlists. From time to time, Invstr will suggest instruments solely based on an individual’s interest and the interest levels of the Invstr community.The statistical and portfolio builder models generated by Invstr do not reflect actual investment results and are not guarantees of future results.Comments provided by Invstr leaders, influencers or members of the Invstr Community are not recommendations and should not be construed as such.Invstr does not endorse the content or the positions posted by them. Their investment approach, and that of the models provided by Invstr, may be different from yours and may not be appropriate for you.